Sex difference in alcoholism: Who is at a greater risk for development of alcoholic complication?

Life Sciences

Volumn 87, Issue 5-6, 2010, Pages 133-138

  Ceylan Isik, Asli F ^a   McBride, Shawna M ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Alcoholism; Dopamine; GABA receptors; NMDA receptors; Sex differences

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 HYDROXYBUTYRIC ACID; ACAMPROSATE; BACLOFEN; BENZODIAZEPINE; BUSPIRONE; CARBAMAZEPINE; DISULFIRAM; DOPAMINE 2 RECEPTOR; DRUGS USED IN THE TREATMENT OF ADDICTION; ESTRADIOL; FLUOXETINE NEFAZODONE; FLUPENTIXOL; GABAPENTIN; LISURIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; NEUROTRANSMITTER; ONDANSETRON; PROGESTERONE; RITANSERIN; SEX HORMONE; SOMATOMEDIN; STEROID HORMONE; TIAPRIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOL WITHDRAWAL; ALCOHOLISM; BRAIN DAMAGE; CLINICAL TRIAL; DEMENTIA; DETOXIFICATION; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG MECHANISM; ENVIRONMENTAL FACTOR; GABAERGIC SYSTEM; GENETIC RISK; HEREDITY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PRENATAL EXPOSURE; PREVALENCE; PSYCHOTHERAPY; RECEPTOR DENSITY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIAL PSYCHOLOGY;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS;

EID: 77954954276     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.06.002     Document Type: Review

References (72)

1. Abramov U., Raud S., Innos J., Koks S., Matsui T., Vasar E. Gender specific effects of ethanol in mice, lacking CCK2 receptors. Behavioural Brain Research 2006, 175:149-156.
2. Aho L., Karkola K., Juusela J., Alafuzoff I. Heavy alcohol consumption and neuropathological lesions: a post-mortem human study. Journal of Neuroscience Research 2009, 87:2786-2792.
3. Alele P.E., Devaud L.L. Differential adaptations in GABAergic and glutamatergic systems during ethanol withdrawal in male and female rats. Alcoholism, Clinical and Experimental Research 2005, 29:1027-1034.
4. Anstey K.J., Mack H.A., Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. The American Journal of Geriatric Psychiatry 2009, 17:542-555.
5. Baliunas D.O., Taylor B.J., Irving H., Roerecke M., Patra J., Mohapatra S., Rehm J. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009, 32:2123-2132.
6. Berman S.M., Ozkaragoz T., Noble E.P., Antolin T., Sheen C., Siddarth P., Conner B.T., Ritchie T. Differential associations of sex and D-2 dopamine receptor (DRD2) genotype with negative affect and other substance abuse risk markers in children of alcoholics. Alcohol 2003, 30:201-210.
7. Bradley K.A., Badrinath S., Bush K., Boyd-Wickizer J., Anawalt B. Medical risks for women who drink alcohol. Journal of General Internal Medicine 1998, 13:627-639.
8. Candore G., Balistreri C.R., Colonna-Romano G., Lio D., Listi F., Vasto S., Caruso C. Gender-related immune-inflammatory factors, age-related diseases, and longevity. Rejuvenation Research 2010, 13:292-297.
9. Chen J.H., Lin K.P., Chen Y.C. Risk factors for dementia. Journal of the Formosan Medical Association 2009, 108:754-764.
10. Cho J.J., Iannucci F.A., Fraile M., Franco J., Alesius T.N., Stefano G.B. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases. Neuro Endocrinology Letters 2003, 24:141-147.
11. Chrostek L., Jelski W., Szmitkowski M., Puchalski Z. Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. Journal of Clinical Laboratory Analysis 2003, 17:93-96.
12. Chung C.Y., Seo H., Sonntag K.C., Brooks A., Lin L., Isacson O. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Human Molecular Genetics 2005, 14:1709-1725.
13. Clarkson E.D., Zawada W.M., Bell K.P., Esplen J.E., Choi P.K., Heidenreich K.A., Freed C.R. IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Experimental Neurology 2001, 168:183-191.
14. Collins M.A., Neafsey E.J., Zou J.Y. HIV-I gpI20 neurotoxicity in brain cultures is prevented by moderate ethanol pretreatment. NeuroReport 2000, 11:1219-1222.
15. Crabb D.W., Matsumoto M., Chang D., You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. The Proceedings of the Nutrition Society 2004, 63:49-63.
16. de Bruin E.A., Pol H.E.H., Schnack H.G., Janssen J., Bijl S., Evans A.C., Kenemans J.L., Kahn R.S., Verbaten M.N. Focal brain matter differences associated with lifetime alcohol intake and visual attention in male but not in female non-alcohol-dependent drinkers. Neuroimage 2005, 26:536-545.
17. de la Monte S.M., Wands J.R. Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. Cellular and Molecular Life Sciences 2002, 59:882-893.
18. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2005, 7:45-61.
19. de la Monte S.M., Ganju N., Banerjee K., Brown N.V., Luong T., Wands J.R. Partial rescue of ethanol-induced neuronal apoptosis by growth factor activation of phosphoinositol-3-kinase. Alcoholism, Clinical and Experimental Research 2000, 24:716-726.
20. de la Monte S.M., Tong M., Cohen A.C., Sheedy D., Harper C., Wands J.R. Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration. Alcoholism, Clinical and Experimental Research 2008, 32:1630-1644.
21. Devaud L.L., Morrow A.L. Gender-selective effects of ethanol dependence on NMDA receptor subunit expression in cerebral cortex, hippocampus and hypothalamus. European Journal of Pharmacology 1999, 369:331-334.
22. Devaud L.L., Fritschy J.M., Morrow A.L. Influence of gender on chronic ethanol-induced alterations in GABA(A) receptors in rats. Brain Research 1998, 796:222-230.
23. Devaud L.L., Matthews D.B., Morrow A.L. Gender impacts behavioral and neurochemical adaptations in ethanol-dependent rats. Pharmacology, Biochemistry and Behavior 1999, 64:841-849.
24. Dodd P.R., Buckley S.T., Eckert A.L., Foley P.F., Innes D.J. Genes and gene expression in the brains of human alcoholics. Ann N Y Acad Sci 2006, 1074:104-115.
25. Duan J., Esberg L.B., Ye G., Borgerding A.J., Ren B.H., Aberle N.S., Epstein P.N., Ren J. Influence of gender on ethanol-induced ventricular myocyte contractile depression in transgenic mice with cardiac overexpression of alcohol dehydrogenase. Comparative Biochemistry and Physiology 2003, 134:607-614.
26. Finn D.A., Beckley E.H., Kaufman K.R., Ford M.M. Manipulation of GABAergic steroids: sex differences in the effects on alcohol drinking- and withdrawal-related behaviors. Hormones and Behavior 2010, 57:12-22.
27. Fratiglioni L., Ahlbom A., Viitanen M., Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Annals of Neurology 1993, 33:258-266.
28. Graves A.B., White E., Koepsell T.D., Reifler B.V., van Belle G., Larson E.B., Raskind M. A case-control study of Alzheimer's disease. Annals of Neurology 1990, 28:766-774.
29. Grobin A.C., Matthews D.B., Devaud L.L., Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 1998, 139:2-19.
30. Henderson V.W., Watt L., Buckwalter J.G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996, 21:421-430.
31. Hillbom M. Alcohol consumption and stroke: benefits and risks. Alcoholism, Clinical and Experimental Research 1998, 22:352S-358S.
32. Hommer D.W. Male and female sensitivity to alcohol-induced brain damage. Alcohol Research & Health 2003, 27:181-185.
33. Huang W., Qiu C., Winblad B., Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75years and older. Journal of Clinical Epidemiology 2002, 55:959-964.
34. Isralowitz R., Spiegel S., Reznik A., Borkin S., Snir Y. Late life alcohol use and gender differences among Former Soviet Union immigrants. Journal of Ethnicity in Substance Abuse 2009, 8:201-205.
35. Johnson B.A. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 2005, 19:873-896.
36. Jorgensen JO Christensen J.J., Vestergaard E., Fisker S., Ovesen P., Christiansen J.S. Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults. Hormone Research 2005, 64(Suppl 2):37-40.
37. Jorgensen J.O., Christensen J.J., Krag M., Fisker S., Ovesen P., Christiansen J.S. Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Hormone Research 2004, 62(Suppl 1):73-76.
38. Kajta M., Budziszewska B., Marszal M., Lason W. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. Journal of Physiology and Pharmacology 2001, 52:437-446.
39. Kalichman S.C., Simbayi L.C., Kaufman M., Cain D., Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prevention Science 2007, 8:141-151.
40. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48:1517-1521.
41. Keller J., Owens C.T., Lai J.C., Devaud L.L. The effects of 17beta-estradiol and ethanol on zinc- or manganese-induced toxicity in SK-N-SH cells. Neurochemistry International 2005, 46:293-303.
42. Kiefer F., Mann K. New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence. European Journal of Pharmacology 2005, 526:163-171.
43. Kishimoto R., Ogishi Y., Ueda M., Matsusaki M., Amako K., Goda K., Park S.S. Gender-related differences in mouse hepatic ethanol metabolism. J Nutr Sci Vitaminol (Tokyo) 2002, 48:216-224.
44. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
45. Letenneur L. Risk of dementia and alcohol and wine consumption: a review of recent results. Biological Research 2004, 37:189-193.
46. Mancinelli R., Vitali M., Ceccanti M. Women, alcohol and the environment: an update and perspectives in neuroscience. Functional Neurology 2009, 24:77-81.
47. Mukamal K.J., Kuller L.H., Fitzpatrick A.L., Longstreth W.T., Mittleman M.A., Siscovick D.S. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289:1405-1413.
48. Nolen-Hoeksema S. Gender differences in risk factors and consequences for alcohol use and problems. Clinical Psychology Review 2004, 24:981-1010.
49. Parlesak A., Billinger M.H., Bode C., Bode J.C. Gastric alcohol dehydrogenase activity in man: influence of gender, age, alcohol consumption and smoking in a caucasian population. Alcohol and Alcoholism 2002, 37:388-393.
50. Patel T.B. Single transmembrane spanning heterotrimeric g protein-coupled receptors and their signaling cascades. Pharmacological Reviews 2004, 56:371-385.
51. Paul C.A., Au R., Fredman L., Massaro J.M., Seshadri S., Decarli C., Wolf P.A. Association of alcohol consumption with brain volume in the Framingham study. Archives of Neurology 2008, 65:1363-1367.
52. Piano M.R., Carrigan T.A., Schwertz D.W. Sex differences in ethanol liquid diet consumption in Sprague-Dawley rats. Alcohol 2005, 35:113-118.
53. Pohjalainen T., Rinne J.O., Nagren K., Syvalahti E., Hietala J. Sex differences in the striatal dopamine D-2 receptor binding characteristics in vivo. The American Journal of Psychiatry 1998, 155:768-773.
54. Prendergast M.A. Do women possess a unique susceptibility to the neurotoxic effects of alcohol?. Journal of the American Medical Women's Association 2004, 59:225-227.
55. Ramachandran V., Perez A., Chen J., Senthil D., Schenker S., Henderson G.I. In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal. Alcoholism, Clinical and Experimental Research 2001, 25:862-871.
56. Ramchandani V.A., Bosron W.F., Li T.K. Research advances in ethanol metabolism. Pathologie Biologie 2001, 49:676-682.
57. Raud S., Runkorg K., Veraksits A., Reimets A., Nelovkov A., Abramov U., Matsui T., Bourin M., Volke V., Koks S., Vasar E. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice. Psychopharmacology (Berl) 2003, 168:417-425.
58. Raud S., Innos J., Abramov U., Reimets A., Koks S., Soosaar A., Matsui T., Vasar E. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test. Psychopharmacology (Berl) 2005, 181:347-357.
59. Richtand N.M., Woods S.C., Berger S.P., Strakowski S.M. D3 dopamine receptor, behavioral sensitization, and psychosis. Neuroscience and Biobehavioral Reviews 2001, 25:427-443.
60. Rosen J., Colantonio A., Becker J.T., Lopez O.L., DeKosky S.T., Moss H.B. Effects of a history of heavy alcohol consumption on Alzheimer's disease. The British Journal of Psychiatry 1993, 163:358-363.
61. Saunders P.A., Copeland J.R., Dewey M.E., Davidson I.A., McWilliam C., Sharma V., Sullivan C. Heavy drinking as a risk factor for depression and dementia in elderly men. Findings from the Liverpool longitudinal community study. Br J Psychiatry 1991, 159:213-216.
62. Schulte M.T., Ramo D., Brown S.A. Gender differences in factors influencing alcohol use and drinking progression among adolescents. Clinical Psychology Review 2009, 29:535-547.
63. Sherwin B.B. Hormones, mood, and cognitive functioning in postmenopausal women. Obstetrics and Gynecology 1996, 87:20S-26S.
64. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 2001, 158:343-359.
65. Soscia S.J., Tong M., Xu X.J., Cohen A.C., Chu J., Wands J.R., de la Monte S.M. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cellular and Molecular Life Sciences 2006, 63:2039-2056.
66. Tadic A., Wagner S., Hoch J., Baskaya O., von Cube R., Skaletz C., Lieb K., Dahmen N. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology 2009, 42:257-263.
67. Tanaka N., Asada T., Kinoshita T., Yamashita F., Uno M. Alcohol consumption and risk of dementia. Lancet 2002, 360:491.
68. Tanev K.S., Roether M., Yang C. Alcohol dementia and thermal dysregulation: a case report and review of the literature. American Journal of Alzheimer's Disease and Other Dementias 2008, 23:563-570.
69. Walter H., Gutierrez K., Ramskogler K., Hertling I., Dvorak A., Lesch O.M. Gender-specific differences in alcoholism: implications for treatment. Archives of Women's Mental Health 2003, 6:253-258.
70. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 2001, 142:969-973.
71. Wodarz N., Bobbe G., Eichhammer P., Weijers H.G., Wiesbeck G.A., Johann M. The candidate gene approach in alcoholism: are there gender-specific differences?. Archives of Women's Mental Health 2003, 6:225-230.
72. Zhang F.X., Rubin R., Rooney T.A. Ethanol induces apoptosis in cerebellar granule neurons by inhibiting insulin-like growth factor 1 signaling. Journal of Neurochemistry 1998, 71:196-204.